Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease - PubMed (original) (raw)

Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease

Jeffrey B Carroll et al. Neurobiol Dis. 2011 Jul.

Abstract

Models of Huntington disease (HD) recapitulate some neuropathological features of the disease. However, a global natural history of neuroanatomy in a mouse expressing full-length huntingtin has not been conducted. We investigated neuropathological changes in the YAC128 murine model of HD using magnetic resonance imaging (MRI). Structures affected in human HD are reduced in the YAC128 mice both in absolute terms and in terms of percentage of brain volume. Structures resistant to degeneration in HD, including the cerebellum and hippocampus, are spared in the YAC128 mice. Segmentation of major white matter structures confirms specific, progressive, loss of white matter in HD. In parallel with their specific volume loss, the YAC128 mice also show progressive increases in total ventricular volume, similarly to human HD patients. Cortical atrophy in the YAC128 mice is layer specific, which is the observed pattern of cortical loss in human HD patients. Finally, we have used a classification tree analysis to maximize separation of genotypes using all 62 structure volumes in an objective manner. This analysis demonstrates that sub-cortical gray matter structures (striatum, globus pallidus, thalamus) and cerebral white matter structures (corpus callosum, anterior commisure, fimbria) are the most discriminatory. The high resolution of the current study enables robust measurement of subtle early pathological changes. The use of mice furthermore enables us to address questions difficult to address in humans, including the sequential changes of HD from baseline and the relation between MRI and stereological measures.

PubMed Disclaimer

Cited by

Choosing an animal model for the study of Huntington's disease.
Pouladi MA, Morton AJ, Hayden MR. Pouladi MA, et al. Nat Rev Neurosci. 2013 Oct;14(10):708-21. doi: 10.1038/nrn3570. Nat Rev Neurosci. 2013. PMID: 24052178 Review.
Age-related mitochondrial alterations in brain and skeletal muscle of the YAC128 model of Huntington disease.
Bečanović K, Asghar M, Gadawska I, Sachdeva S, Walker D, Lazarowski ER, Franciosi S, Park KHJ, Côté HCF, Leavitt BR. Bečanović K, et al. NPJ Aging Mech Dis. 2021 Oct 14;7(1):26. doi: 10.1038/s41514-021-00079-2. NPJ Aging Mech Dis. 2021. PMID: 34650085 Free PMC article.
Wanted dead or alive? The tradeoff between in-vivo versus ex-vivo MR brain imaging in the mouse.
Lerch JP, Gazdzinski L, Germann J, Sled JG, Henkelman RM, Nieman BJ. Lerch JP, et al. Front Neuroinform. 2012 Mar 23;6:6. doi: 10.3389/fninf.2012.00006. eCollection 2012. Front Neuroinform. 2012. PMID: 22470335 Free PMC article.
In Vivo MRI Evidence that Neuropathology is Attenuated by Cognitive Enrichment in the Yac128 Huntington's Disease Mouse Model.
Steventon JJ, Harrison DJ, Trueman RC, Rosser AE, Jones DK, Brooks SP. Steventon JJ, et al. J Huntingtons Dis. 2015;4(2):149-60. doi: 10.3233/JHD-150147. J Huntingtons Dis. 2015. PMID: 26397896 Free PMC article.
An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes.
Southwell AL, Smith-Dijak A, Kay C, Sepers M, Villanueva EB, Parsons MP, Xie Y, Anderson L, Felczak B, Waltl S, Ko S, Cheung D, Dal Cengio L, Slama R, Petoukhov E, Raymond LA, Hayden MR. Southwell AL, et al. Hum Mol Genet. 2016 Sep 1;25(17):3654-3675. doi: 10.1093/hmg/ddw212. Epub 2016 Jul 4. Hum Mol Genet. 2016. PMID: 27378694 Free PMC article.

Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease - PubMed (original) (raw)